In last trading session, Sonoma Pharmaceuticals Inc (NASDAQ:SNOA) saw 0.13 million shares changing hands with its beta currently measuring 1.44. Company’s recent per share price level of $2.79 trading at -$0.13 or -4.45% at ring of the bell on the day assigns it a market valuation of $3.74M. That closing price of SNOA’s stock is at a discount of -235.84% from its 52-week high price of $9.37 and is indicating a premium of 9.68% from its 52-week low price of $2.52. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 1.12 million shares which gives us an average trading volume of 337.32K if we extend that period to 3-months.
Sonoma Pharmaceuticals Inc (NASDAQ:SNOA) trade information
Upright in the red during last session for losing -4.45%, in the last five days SNOA remained trading in the red while hitting it’s week-highest on Friday, 11/22/24 when the stock touched $2.79 price level, adding 11.15% to its value on the day. Sonoma Pharmaceuticals Inc’s shares saw a change of -22.67% in year-to-date performance and have moved -1.76% in past 5-day. Sonoma Pharmaceuticals Inc (NASDAQ:SNOA) showed a performance of -3.79% in past 30-days. Number of shares sold short was 79898.0 shares which calculate 0.22 days to cover the short interests.
Sonoma Pharmaceuticals Inc (SNOA) estimates and forecasts
Statistics highlight that Sonoma Pharmaceuticals Inc is scoring comparatively higher than the scores of other players of the relevant industry. The company lost -31.95% of value to its shares in past 6 months, showing an annual growth rate of 47.37% while that of industry is 17.00. Apart from that, the company came raising its revenue forecast for fiscal year 2024. This year revenue growth is estimated to rise 21.48% from the last financial year’s standing.
1 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 4.06M for the same. And 1 analysts are in estimates of company making revenue of 4.44M in the next quarter. Company posted 3.14M and 3.44M of sales in current and next quarters respectively a year earlier.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 47.04% during past 5 years.
Sonoma Pharmaceuticals Inc (NASDAQ:SNOA)’s Major holders
Insiders are in possession of 1.51% of company’s total shares while institution are holding 2.42 percent of that, with stock having share float percentage of 2.45%. Investors also watch the number of corporate investors in a company very closely, which is 2.42% institutions for Sonoma Pharmaceuticals Inc that are currently holding shares of the company. CITADEL ADVISORS LLC is the top institutional holder at SNOA for having 0.2 million shares of worth $41412.0. And as of 2024-06-30, it was holding 1.2504 of the company’s outstanding shares.
The second largest institutional holder is GEODE CAPITAL MANAGEMENT, LLC, which was holding about 86644.0 shares on 2024-06-30. The number of shares represents firm’s hold over 0.5551 of outstanding shares, having a total worth of $18385.0.
